Related references
Note: Only part of the references are listed.The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2023)
Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy
Samuel A. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Elevation in Circulating Soluble CD40 Ligand Concentrations in Type 2 Diabetic Retinopathy and Association with its Severity
Laila Ben Lamine et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2020)
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
Ines P. Marques et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
The association between impaired glucose tolerance and soluble CD40 ligand: a 15-year prospective cohort study
Hannamari Linna et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Steven F. Abcouwer et al.
YEAR IN DIABETES AND OBESITY (2014)
Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy
Zongming Song et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway
Yong Liu et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2014)
CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
Zhiwei Tang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Nerve growth factor in diabetic retinopathy: beyond neurons
Barbara A. Mysona et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2014)
Soluble Mediators of Diabetic Macular Edema: The Diagnostic Role of Aqueous VEGF and Cytokine Levels in Diabetic Macular Edema
Leah A. Owen et al.
CURRENT DIABETES REPORTS (2013)
Correlation of complement fragment C5a with inflammatory cytokines in the vitreous of patients with proliferative diabetic retinopathy
Daisuke Muramatsu et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
The CD40/CD4OL system: A new therapeutic target for disease
Bikui Zhang et al.
IMMUNOLOGY LETTERS (2013)
Biomarkers in Diabetic Retinopathy and the Therapeutic Implications
Katarzyna Zorena et al.
MEDIATORS OF INFLAMMATION (2013)
EFFECTS OF SOLUBLE CD14 AND CYTOKINE LEVELS ON DIABETIC MACULAR EDEMA AND VISUAL ACUITY
Kazuhiko Umazume et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Genetics of Diabetic Retinopathy
Ahmed F. Omar et al.
SEMINARS IN OPHTHALMOLOGY (2013)
Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion
Won June Lee et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Role of Fractalkine/CX3CR1 Interaction in Light-Induced Photoreceptor Degeneration through Regulating Retinal Microglial Activation and Migration
Meng Zhang et al.
PLOS ONE (2012)
Immune Mediators in Vitreous Fluids from Patients with Vitreoretinal B-Cell Lymphoma
Yoshihiko Usui et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
INCREASES OF VITREOUS MONOCYTE CHEMOTACTIC PROTEIN 1 AND INTERLEUKIN 8 LEVELS IN PATIENTS WITH CONCURRENT HYPERTENSION AND DIABETIC RETINOPATHY
Yoshihiro Wakabayashi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Increased levels of 8-hydroxydeoxyguanosine in the vitreous of patients with diabetic retinopathy
Yoshihiro Wakabayashi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
CORRELATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR WITH CHEMOKINES IN THE VITREOUS IN DIABETIC RETINOPATHY
Yoshihiro Wakabayashi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Alterations in the Intraocular Cytokine Milieu after Intravitreal Bevacizumab
Farzin Forooghian et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Mediators of ocular angiogenesis
Yureeda Qazi et al.
JOURNAL OF GENETICS (2009)
Proliferative Diabetic Retinopathy with Lymphocyte-Rich Epiretinal Membrane Associated with Poor Visual Prognosis
Satoru Kase et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Diabetic Retinopathy and Angiogenesis
Talia N. Crawford et al.
CURRENT DIABETES REVIEWS (2009)
Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy
Akihiro Kakehashi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes - The DCCT/EDIC genetics study
Hussam Al-Kateb et al.
DIABETES (2007)
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus:: effect of improved metabolic control
F Cipollone et al.
DIABETOLOGIA (2005)
Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro
M Berkkanoglu et al.
MOLECULAR HUMAN REPRODUCTION (2004)
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema
H Funatsu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Subclassification of preproliferative diabetic retinopathy and glycemic control:: Relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy
Y Sato et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2001)
Share Paper
